Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma

European Journal of Cancer

Volumn 43, Issue 4, 2007, Pages 809-815

  Zhou, Li ^a   He, Xiao Dong ^a   Chen, Jie ^a   Cui, Quan Cai ^a   Qu, Qiang ^a   Rui, Jing An ^a   Zhao, Yu Pei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Gallbladder carcinoma; Immunohistochemistry; LAPTM4B 35; Survival

Indexed keywords

LYSOSOME ASSOCIATED PROTEIN TRANSMEMBRANE 4 BETA 35; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GALLBLADDER CARCINOMA; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS; POSTOPERATIVE PERIOD; TUMOR MARKERS, BIOLOGICAL;

EID: 33947623242     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.10.025     Document Type: Article

References (25)

1. Koea J., Phillips A., Lawes C., et al. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival. ANZ J Surg 72 (2002) 857-861
2. Wood R., Fraser L.A., Brewster D.H., and Garden O.J. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer 39 (2003) 2080-2086
3. Paltoo D.N., and Chu K.C. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999. Public Health Rep 119 (2004) 443-451
4. Marrett L.D., and Chaudhry M. Cancer incidence and mortality in Ontario First Nations, 1968-1991 (Canada). Cancer Causes Control 14 (2003) 259-268
5. Kuzmickiene I., Didziapetris R., and Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med 46 (2004) 147-153
6. Hsing A.W., Gao Y.T., Devesa S.S., Jin F., and Fraumeni Jr. J.F. Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 75 (1998) 368-370
7. da Rocha A.O., Coutinho L.M., Scholl J.G., and Leboutte L.D. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases. Hepatogastroenterology 51 (2004) 1310-1314
8. Singh M.K., Chetri K., Pandey U.B., et al. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol 19 (2004) 916-921
9. Chang H.J., Jee C.D., and Kim W.H. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 26 (2002) 758-766
10. Hui A.M., Li X., Shi Y.Z., et al. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 6 (2000) 4272-4277
11. Hui A.M., Li X., Shi Y.Z., et al. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 31 (2000) 1068-1072
12. Chang H.J., Kim S.W., Lee B.L., Hong E.K., and Kim W.H. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis. Pathol Int 54 (2004) 576-584
13. Liu J., Zhou R., Zhang N., Rui J., and Jin C. Biological function of a novel gene overexpressed in human hepatocellular carcinoma. Chin Med J 113 (2000) 881-885
14. Shao G.Z., Zhou R.L., Zhang Q.Y., et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogen. 22 (2003) 5060-5069
15. Liu X.R., Zhou R.L., Zhang Q.Y., et al. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. World J Gastroenterol 10 (2004) 1555-1559
16. Peng C., Zhou R.L., Shao G.Z., et al. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol 11 (2005) 2704-2708
17. Kasper G., Vogel A., Klaman I., et al. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett 224 (2005) 93-103
18. Morris D.G., Musat M., Czirjak S., et al. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153 (2005) 143-151
19. Nevin J.E., Moran T.J., Kay S., and King R. Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer 37 (1976) 141-148
20. Malik I.A. Gallbladder cancer: current status. Expert Opin Pharmacother 5 (2004) 1271-1277
21. Dixon E., Vollmer Jr. C.M., Sahajpal A., et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241 (2005) 385-394
22. Hogue D.L., Kerby L., and Ling V. A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae. J Biol Chem 274 (1999) 12877-12882
23. Noshiro H., Chijiiwa K., Yamaguchi K., et al. Factors affecting surgical outcome for gallbladder carcinoma. Hepatogastroenterology 50 (2003) 939-944
24. Taner C.B., Nagorney D.M., and Donohue J.H. Surgical treatment of gallbladder cancer. J Gastrointest Surg 8 (2004) 83-89
25. Varga M., Obrist P., Schneeberger S., et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10 (2004) 3131-3136